Links

Homepage

Stock List

Search by Ticker

News

Login

Boston Scientific Corporation (NYSE:BSX)
Stock Analysis

BSX33.81
▼ -1%-0.34

Stock Analysis

The following stock analysis is based on 1.5 years of data (i.e. since May 28, 2019). All the stock history has been downloaded.

Stock Exchange

Boston Scientific Corporation trades on the NYSE exchange in USD dollars.

Sector

It is in the sector.

Current Status of Boston Scientific Corporation

It is currently trading at $33.81 ($34.15 the previous day).

Financials

The next reporting date is in 68 days (2021 02 10).

CNN estimates profits for the upcoming quarter will be $0.33 per share ($2.9B). The current Canada / US exchange rate is 1.2863.



Over the past 12 months, $0 worth of shares have been purchased and $22254915 worth of shares have been sold by insiders.

Will This Trend Continue?

The year over year average increase is -7.5% per year assuming steady exponential growth. The actual 5 year average is -8.2. Details on the individual increase in one year intervals is provided below.

Past PerformanceAverage PricePercent Change
1 year38.211105263158-8.2
2 year41.6190860215050+ Above Average
3 year0+ Above Average
4 year0+ Above Average
5 year0+ Above Average
Boston Scientific Corporation is projected by analysts to get to $43.00 within the next 12 months (27.2%), but preticted targets range from as high as $50.00 (47.9%) and as low as $40(18.3%).

Risk

The worst drop it has had in recent years is -40.7%. It has a shape to the stock curve, which means

Stock shape test

DAYS AG0PRICE
1033.7RISING
3037.17DROPPING
6037.34DROPPING
15034.65RISING
36543.25DROPPING
800RISING
1200RISING
1600RISING
2000RISING


The P/E value is 12.98.

Tradingview BuySell Widget

Yahoo News Feed

Boston Scientific (BSX) to Divest BTG's Non-MedTech Arm

Wed, 02 Dec 2020 14:41:02 BTG's core Interventional Medicines business now is expected to exceed Boston Scientific's (BSX) original goal of $175 million in synergies.... Read Full Article

Boston Scientific to Sell BTG Specialty Pharma for $800 Million

Tue, 01 Dec 2020 15:33:00 Boston Scientific agreed to sell its BTG Specialty Pharmaceuticals for $800 million cash to affiliates of the Brussels drugmaker Serb SAS.... Read Full Article

The Daily Biotech Pulse: Pfizer, BioNTech File Marketing Application In Europe, NuCana Jumps On Data, Amarin Takes On Hikma In Patent Lawsuit

Tue, 01 Dec 2020 13:08:03 Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 30) * Amicus Therapeutics, Inc. (NASDAQ: FOLD) * Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) * argenx SE - ADR (NASDAQ: ARGX) * ...... Read Full Article

Boston Scientific sells BTG specialty pharma business to SERB affiliates for $800 million in cash

Tue, 01 Dec 2020 12:04:00 Boston Scientific Corp. said Tuesday it is selling its BTG Specialty Pharmaceuticals business to Stark International Lux S.A.R.L. and SERB SAS, both affiliates of specialty pharma group SERB, for $800 million in cash. SERB is backed by private-equity ...... Read Full Article

Boston Scientific's Debt Overview

Tue, 01 Dec 2020 11:57:59 Over the past three months, shares of Boston Scientific (NYSE: BSX) moved lower by 20.08%. Before we understand the importance of debt, let us look at how much debt Boston Scientific has.Boston Scientific's Debt According to the Boston Scientific's most ...... Read Full Article

Boston Scientific Signs Definitive Agreement to Divest BTG Specialty Pharmaceuticals Business

Tue, 01 Dec 2020 11:30:00 Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a definitive agreement with Stark International Lux S.A.R.L., and SERB SAS, affiliates of SERB, a European specialty pharmaceutical group, to sell its BTG Specialty Pharmaceuticals ...... Read Full Article

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Boston Scientific Corporation - BSX

Sun, 29 Nov 2020 03:00:00 NEW YORK, NY / ACCESSWIRE / November 28, 2020 / Pomerantz LLP is investigating claims on behalf of investors of Boston Scientific Corporation ("Boston Scientific" or the "Company") (NYSE:BSX).... Read Full Article

Where to Invest in 2021

Sat, 28 Nov 2020 19:45:37 With the election in the rearview mirror, investors can turn their full attention to the economic recovery and progress on the pandemic.... Read Full Article

Why Is Boston Scientific (BSX) Down 1.5% Since Last Earnings Report?

Fri, 27 Nov 2020 16:31:04 Boston Scientific (BSX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.... Read Full Article

Boston Scientific to Participate in Evercore ISI 2020 Healthcare Conference

Mon, 23 Nov 2020 14:30:00 Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2020 Evercore ISI HealthCONx Conference on December 1.... Read Full Article

Investor Alert: Kaplan Fox Continues To Investigate Boston Scientific Corporation (BSX)

Fri, 20 Nov 2020 22:00:00 Kaplan Fox and Kilsheimer LLP (www.kaplanfox.com) has been investigating potential claims against Boston Scientific Corporation (NYSE: BSX) ("BSX" or the "Company") for violations of the federal securities laws.... Read Full Article

Investor Alert: Kaplan Fox Investigates Boston Scientific Corporation (BSX)

Wed, 18 Nov 2020 19:26:00 NEW YORK, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Kaplan Fox and Kilsheimer LLP (www.kaplanfox.com) is investigating potential claims against Boston Scientific Corporation (“BSX” or the “Company”) (NYSE:BSX) for violations of the federal securities laws. BSX’s Lotus Edge is ...... Read Full Article

Bronstein, Gewirtz and Grossman, LLC Notifies Boston Scientific Corporation (BSX) Investors of Investigation

Wed, 18 Nov 2020 16:15:00 NEW YORK, NY / ACCESSWIRE / November 18, 2020 / Bronstein, Gewirtz and Grossman, LLC is investigating potential claims on behalf of purchasers of Boston Scientific Corporation ("Boston Scientific" or the "Company") (NASDAQ:BSX).... Read Full Article

Boston Scientific Sacrifices Its Double-Bottom Base On Product Recall

Tue, 17 Nov 2020 21:44:50 Boston Scientific recalled its Lotus Edge transcatheter heart-valve replacement system on Tuesday — sending BSX stock into a tailspin. The medical device gained FDA approval in 2019.... Read Full Article

Boston Scientific Shares Drop After Lotus Aortic Valve Recall

Tue, 17 Nov 2020 15:48:00 Boston Scientific is lower after the medical-device maker stops producing its Lotus Edge Aortic Valve due to issues with its delivery system.... Read Full Article

The Daily Biotech Pulse: Setback For Alkermes, Boston Scientific's Recall, ALX-Zymeworks Oncology Collaboration

Tue, 17 Nov 2020 13:31:52 Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 16) * Aligos Therapeutics Inc (NASDAQ: ALGS) (announced multiple presentations at the Liver Meeting) * Amicus Therapeutics, Inc. (NASDAQ: FOLD) * ...... Read Full Article

Boston Scientific to voluntarily recall LOTUS Edge aortic valve system due to snag with delivery system

Tue, 17 Nov 2020 11:13:00 Boston Scientific Corp. said Tuesday it has launched a voluntary recall of unused stock of its LOTUS Edge Aortic Valve System due to "complexities" relating to the product delivery system. "The voluntary recall is related solely to the delivery system, ...... Read Full Article

Boston Scientific Announces LOTUS Edge™ Aortic Valve System Voluntary Recall and Product Discontinuation

Tue, 17 Nov 2020 11:00:00 Boston Scientific Corporation (NYSE: BSX) has announced it has initiated a global, voluntary recall of all unused inventory of the LOTUS Edge™ Aortic Valve System due to complexities associated with the product delivery system. The voluntary recall is related solely ...... Read Full Article

IBD Stock Of The Day Inari Medical Eyes Fresh Buy Point After Bullish IPO

Fri, 13 Nov 2020 21:30:57 Inari Medical is the IBD Stock Of The Day as shares eye a fresh buy point. Shares of NARI stock have almost quadrupled from the asking price at the company's initial public offering in May.... Read Full Article

Boston Scientific (BSX) in Focus: Stock Moves 7% Higher

Tue, 10 Nov 2020 13:33:01 Boston Scientific (BSX) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.... Read Full Article
<